ALPS Launches Organoid Program
Alps Group Inc launches patient-derived organoid program to advance personalized cancer care in Southeast Asia
ALPS - Alps Group Inc Launches Patient-Derived Organoid Program to Advance Personalized Cancer Care in Southeast AsiaAgreement Marks Company's Expansion into Precision Oncology Testing, with the Goal of Establishing Malaysia's First Clinically Validated PDO Platform